Proliferative vitreoretinopathy
Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
5
Timing and outcomes after silicone oil removal in proliferative vitreoretinopathy: a retrospective clinical series
5
Clinical and surgical risk factors in the development of proliferative vitreoretinopathy following retinal detachment surgery: a systematic review protocol
5
Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in <em>CAPN5</em>-associated proliferative vitreoretinopathy
6
Ozurdex® (a slow release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial
8
Prophylactic intravitreal 5 fluorouracil and heparin to prevent proliferative vitreoretinopathy in high risk patients with retinal detachment: study protocol for a randomized controlled trial
13
Steroids as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a systematic review and meta-analysis
8
Retinotomy with retinal turnover to remove subretinal membranes under direct visualization for proliferative vitreoretinopathy
8
Relaxing retinotomies and retinectomies in the management of retinal detachment with severe proliferative vitreoretinopathy (PVR)
8
Anatomic and functional outcomes of retinectomy for the management of complicated retinal detachment with proliferative vitreoretinopathy
7
Dashed line relaxing retinotomy in the management of retinal detachment with anterior proliferative vitreoretinopathy
6
Proliferative vitreoretinopathy: current and emerging treatments
9
Intravitreal methotrexate infusion for proliferative vitreoretinopathy
7
Proliferative vitreoretinopathy (PVR) - The use of adjuvant therapy in the preventative treatment of PVR and the study of clinical and biological risk factors
264
Obermann, Jara (2018): Galectins and modulation of glycomic fingerprints of retinal pigment epithelial cells as a novel therapeutic approach for proliferative vitreoretinopathy. Dissertation, LMU München: Medizinische Fakultät
149
Valved versus nonvalved cannula small-gauge pars plana vitrectomy for repair of retinal detachments with Grade C proliferative vitreoretinopathy
6
Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E
9
A pilot study of intraocular use of intensive anti inflammatory; triamcinolone acetonide to prevent proliferative vitreoretinopathy in eyes undergoing vitreoretinal surgery for open globe trauma; the adjuncts in ocular trauma (AOT) trial: study protocol for a randomised controlled trial
8
The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice
10
Epiretinal membrane and cystoid macular edema as predictive factors of recurrent proliferative vitreoretinopathy
6